PTA Balloon Catheter Market Projected to Grow Steadily During 2018-2026

PTA Balloon Catheter Market Outlook 2018 Sales
Revenue, Strategy to 2026
PTA Balloon Catheter Market by Material Type (Polyurethane, Nylon, and
Others), by Application (Coronary Artery Disease and Peripheral Vascular
Disease), by End User (Hospitals or Clinics, Ambulatory Surgical Centers, and
Others), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026
A catheter is a tubular, flexible instrument, passed through body channels for withdrawals of fluid (or
introduction of fluids) from body cavity. PTA balloon catheter is an innovative medical device, which is
inserted in the femoral artery in the leg or sometimes into the radial artery in the arm for the treatment
of constricted blood vessels. The PTA means “percutaneous transluminal angioplasty” (percutaneous
means through the skin). As the balloon inflates, the cage causes the balloon to form a series of
segmented pillows and grooves along the entire lesion. The pillows apply force to create small
dissections that are necessary for effective dilatation. The grooves relieve the stress and stop dissections
from propagating. The PTA balloon catheters is used in for the treatment of peripheral vascular lesions.
Request For a Sample Copy of This Business Report @
https://www.coherentmarketinsights.com/insight/request-sample/2815
Market Dynamics
Increasing prevalence of urological and cardiovascular diseases, geographical expansion of PTA
balloons catheter manufacturers in North America, and increasing investment in research and
development by manufacturers are some of the major factors that are expected to drive the market
growth. Furthermore, increasing production of PTA balloon catheter is expected to driving growth of
global PTA balloon catheter market. For instance, in April 2015, BrosMed announced CE mark and
launched its Minerva percutaneous transluminal angioplasty (PTA) dilation catheter for the treatment of
patients with peripheral arterial disease.
Increasing prevalence of urological and cardiovascular diseases is expected to propel the PTA
balloon catheter market growth
Increasing prevalence of urological and cardiovascular diseases is expected to increase demand for PTA
balloon catheters, which in turn is expected to fuel the PTA balloon catheter market growth over the
forecast period. The urological diseases include, urinary tract infections, kidney stones, and prostate
problems. According to, the American Cancer Society around 174,650 new cases and around 31,620
deaths occurs due to prostate cancer the U.S. in 2019. According to National Institute of Diabetes and
Digestive and Kidney Diseases, in 2017, around 11% of men and 6% of women in the U.S. suffered
from kidney stone.
Furthermore, according to the World Health Organization, cardiovascular diseases account for most of
the non-communicable disease deaths. An estimated 17.9 million deaths were registered from
cardiovascular diseases in 2016, representing 31% of the global deaths. Of these deaths, 85% were due
to heart attack and stroke. Therefore, increasing prevalence of non-communicable diseases is expected
to increase demand for catheters, which in turn is expected to drive growth of the PTA Balloon
Catheter Market over the forecast period.
Key Players
Major players operating in the global PTA balloon catheter market include, Medtronic, Terumo,
Cardinal Health, Boston Scientific, AndraTec, Cook Medical, Biotronik, Abbott, Creagh Medical,
TriReme Medical, and Natec Medical.
Detailed Segmentation:
•Global PTA balloon catheter Market, By Material Type:
•Polyurethane
•Nylon
•Others
•Global PTA balloon catheter Market, By Application:
•Coronary Artery Disease
•Peripheral Vascular Disease
•Global PTA balloon catheter Market, By End User:
•Hospitals and Clinics
•Ambulatory Surgical Centers
•Others
Increasing Launch of New Products Is Expected To Boost the PTA Balloon Catheter Market
Growth in North America
Major PTA balloon catheter manufacturers are focused on launching new products in North America to
enhance their market share. For instance, in February 2016, Nipro North America, a division of Nipro
Medical Corporation, announced the launch of Cronus HP high pressure, 0.035” over the wire (OTW)
percutaneous transluminal angioplasty (PTA) balloon catheter. Cronus HP is indicated for percutaneous
transluminal angioplasty in the femoral, popliteal, iliac, and renal arteries and for the treatment of
obstructive lesions in native or synthetic arteriovenous dialysis fistulae.
Moreover, in February 2017, QT Vascular Ltd. signed an exclusive, worldwide distribution agreement
with Medtronic to distribute the Chocolate PTA balloon catheter. It is currently available in the U.S.
and Europe.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]

A catheter is a tubular, flexible instrument, passed through body channels for withdrawals of fluid (or introduction of fluids) from body cavity. PTA balloon catheter is an innovative medical device, which is inserted in the femoral artery in the leg or sometimes into the radial artery in the arm for the treatment of constricted blood vessels.

Download Report